Have questions for our experts or want more information?
Contact Us Today
USP <73> Webinar Overview
The introduction of USP <73> is complex, yet it opens new doors for contract testing labs and advanced therapy manufacturers to accelerate sterility testing. At the same time, this update enhances the safety of short-life products while ensuring compliance with regulatory standards.
This webinar highlights how a leading contract lab successfully validated and implemented ATP-bioluminescence for microbial detection in compliance with European Pharmacopeia 5.1.6 and USP <1223>, and will subsequently comply with USP <73> upon its release. A case study will be presented, which explores their approach and how the method is adaptable to your sterility testing.
You will learn:
- Key USP <73> insights and how they impact your cell and gene sterility testing
- How ATP-bioluminescence has evolved to test for advanced medicinal therapies
- The adaptable approach to achieve faster and more reliable microbial detection
Webinar Presenters
Stefan Gärtner
Head of Department, Test for Sterility
Labor LS
Stacey Ramsey, MS
Senior Manager, Celsis® & Microbial Applications Lab
Charles River
Additional Information
- Accelerating Contamination Detection in Short-Life Products with Celsis®
- Rapid Sterility Test Systems for Advanced Therapies
- The Future of Sterility Testing for Short Shelf Life Products
- Discover How Adopting Rapid Microbial Testing Methods Can Transform Your Contract Testing Laboratory
The Micro Keeps You in The Know
You don't need an agar plate to grow your microbial knowledge. Get industry updates, articles and other resources delivered straight to your inbox each month with this microbiology newsletter.
Subscribe